Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07359664
Recruiting
OCTA in Cardiovascular Disease and Healthy Controls
Not applicable · Germany · 1 site
Registry update: 22 Jan 2026
NCT07281716
Recruiting
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC
Phase 1/2 · United States · 1 site
Registry update: 19 Feb 2026
NCT07229170
Recruiting
Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients
Not applicable · Italy · 3 sites
Registry update: 28 Apr 2026
NCT07284186
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Phase 1 · United States · 10 sites
Registry update: 12 Jun 2026
NCT07275749
Recruiting
Acetyl-leucine in Post-stroke Ataxia
Phase 3 · Egypt · 1 site
Registry update: 10 Dec 2025
NCT07644286
Recruiting
A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal Cancer
Phase 2 · China · 1 site
Registry update: 12 Jun 2026
NCT07357571
Recruiting
Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound
Not applicable · China · 2 sites
Registry update: 22 Jan 2026
NCT07282353
Recruiting
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · China · 42 sites
Registry update: 8 Jul 2026
NCT07216014
Recruiting
Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Phase 4 · China · 1 site
Registry update: 24 Apr 2026
NCT07304375
Recruiting
Effects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple Sclerosis
Not applicable · Denmark · 2 sites
Registry update: 8 Jan 2026
NCT07243691
Recruiting
Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma
Not applicable · China · 1 site
Registry update: 24 Nov 2025
NCT07050745
Recruiting
Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
Not applicable · Kenya · 1 site
Registry update: 12 Jan 2026
NCT05517980
Recruiting
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis
Phase 2 · China · 1 site
Registry update: 3 Nov 2026
NCT07395232
Recruiting
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Phase 3 · Spain, Italy, United States · 19 sites
Registry update: 21 Sept 2026
NCT07392346
Recruiting
Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer
Phase 2 · China · 1 site
Registry update: 11 Feb 2026
NCT07347041
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA)
Not applicable · China · 1 site
Registry update: 16 Jan 2026
NCT07263321
Recruiting
Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.
Not applicable · Denmark · 1 site
Registry update: 10 Dec 2025
NCT07235384
Recruiting
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
Phase 1 · Australia, China, New Zealand · 14 sites
Registry update: 4 Nov 2026
NCT07483125
Recruiting
Valsalva SBP Drop and LVOT Obstruction
Not applicable · China · 1 site
Registry update: 19 Mar 2026
NCT06980636
Recruiting
A Trial of Shengmai Liquid for Long COVID Fatigue.
Phase 4 · China · 1 site
Registry update: 9 Feb 2026

Ordered by registry start date. Freshness and sponsorship never change the order.